Versant Venture Management, LLC Aligos Therapeutics, Inc. Transaction History
Versant Venture Management, LLC
- $71.7 Million
- Q1 2024
A detailed history of Versant Venture Management, LLC transactions in Aligos Therapeutics, Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 2,320,381 shares of ALGS stock, worth $1.37 Million. This represents 3.17% of its overall portfolio holdings.
Number of Shares
2,320,381
Previous 2,320,381
-0.0%
Holding current value
$1.37 Million
Previous $1.53 Million
48.47%
% of portfolio
3.17%
Previous 2.25%
Shares
2 transactions
Others Institutions Holding ALGS
# of Institutions
53Shares Held
46.2MCall Options Held
6.11MPut Options Held
200-
Armistice Capital, LLC New York, NY6.89MShares$4.07 Million0.09% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.39MShares$3.77 Million0.18% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.1MShares$3.6 Million0.2% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$2.09 Million0.46% of portfolio
-
Altitude Crest Partners Inc. Stamford, CT2.84MShares$1.68 Million1.19% of portfolio
About Aligos Therapeutics, Inc.
- Ticker ALGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,717,000
- Market Cap $23.4M
- Description
- Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...